Log In
BCIQ
Print this Print this
 

M2951, MSC2364447C

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionBruton's tyrosine kinase (Btk) inhibitor
Molecular Target Bruton's tyrosine kinase (Btk)
Mechanism of ActionBruton's tyrosine kinase (Btk) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today